Browse Locations ... - Condition: Cancer
Intervention: Device: Magnetic Resonance Imaging (MRI)
Sponsors: Institute of Cancer Research, United Kingdom; Institute of Cancer Research, United Kingdom; Cancer Research UK
Not yet recruiting - verified June 2013 - Conditions: C.Surgical Procedure; Cardiac; Haemorrhage.
Interventions: Device: 032-11; Device: Floseal (R)
Sponsors: Medtrade; Medtrade; The Clinical Trial Company, Knutsford, United Kingdom
Not yet recruiting - verified June 2013 - Condition: Tuberculosis (TB)
Interventions: Biological: MVA85A-IMX313; Biological: MVA85A
Sponsors: University of Oxford; University of Oxford; Imaxio
Not yet recruiting - verified June 2013 - Conditions: Heart Failure; Heart-Assist Devices
Intervention: Device: CircuLite Synergy left ventricular assist device
Sponsors: Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Universitaire Ziekenhuizen Leuven
Not yet recruiting - verified June 2013 - Conditions: Crohn's Disease; Recurrence
Interventions: Procedure: Extended resection; Procedure: Conventional resection
Sponsors: Oxford University Hospitals NHS Trust; Oxford University Hospitals NHS Trust
Active, not recruiting - verified June 2013 - Conditions: Retinitis Pigmentosa; Age-related Macular Degeneration; Optic Nerve Pathology; Inherited Retinal Dystrophies
Intervention:
Sponsors: University of Oxford; University of Oxford
Recruiting - verified June 2013 - Condition: Cellulitis
Interventions: Drug: Flucloxacillin and Clindamycin; Drug: Flucloxacillin and placebo
Sponsors: University Hospitals Bristol NHS Trust; University Hospitals Bristol NHS Trust; University of Bristol; Health Protection Agency, United Kingdom
Not yet recruiting - verified June 2013 - Condition: No Conditions. Qualitative Study Using Interpretative Phenomenological Analysis Method
Intervention:
Sponsors: University of Surrey; University of Surrey; Royal Marsden NHS Foundation Trust
Recruiting - verified June 2013 - Condition: Diabetes
Intervention:
Sponsors: Tameside Hospital NHS Foundation Trust; Tameside Hospital NHS Foundation Trust
Not yet recruiting - verified June 2013 - Condition: Refractive Error
Interventions: Device: delefilcon A; Device: narafilcon B
Sponsors: Vistakon; Vistakon
Not yet recruiting - verified June 2013 - Condition: Cystic Fibrosis
Intervention: Other: home monitoring
Sponsors: Papworth Hospital; Papworth Hospital
Active, not recruiting - verified June 2013 - Condition: Rhinitis
Intervention:
Sponsors: Research in Real-Life Ltd; Research in Real-Life Ltd; Meda Pharmaceuticals
Completed - verified June 2013 - Condition: Oropharyngeal Squamous Cell Carcinoma
Interventions: Drug: Cisplatin; Drug: Cetuximab
Sponsors: University of Warwick; University of Warwick; Cancer Research UK
Recruiting - verified June 2013 - Conditions: Inflammatory Arthritis; Rheumatoid Arthritis; Hand Osteoarthritis
Intervention: Device: Compression glove
Sponsors: University of Salford; University of Salford
Not yet recruiting - verified June 2013 - Condition: Arthritis of Knee
Intervention: Drug: Ropivacaine
Sponsors: Golden Jubilee National Hospital; Golden Jubilee National Hospital; B. Braun Medical Inc.; University of Strathclyde
Completed - verified June 2013 - Conditions: Diabetes Mellitus; Diabetes Mellitus, Type 1; Glucose Metabolism Disorders; Endocrine System Diseases; Autoimmune Diseases
Interventions: Device: Closed-loop system; Device: real-time CGM
Sponsors: University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust
Not yet recruiting - verified June 2013 - Condition: Unipolar Major Depressive Disorder
Interventions: Device: Transcranial direct current stimulation (tDCS); Behavioral: Cognitive Behavioural Therapy
Sponsors: University College, London; University College, London
Not yet recruiting - verified May 2013 - Conditions: Infertility; Monofollicular Development
Intervention: Drug: Gonal-f®
Sponsors: Merck KGaA; Merck KGaA
Recruiting - verified June 2013 - Condition: Dyslipidemia
Interventions: Drug: TA-8995; Drug: TA-8995; Drug: TA-8995; Drug: TA-8995; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo
Sponsors: Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma Corporation
Completed - verified June 2013 - Condition: Spondylitis, Ankylosing
Interventions: Drug: Ixekizumab; Drug: Placebo; Drug: Adalimumab
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Not yet recruiting - verified June 2013 - Condition: Hypertension
Interventions: Drug: LCZ696; Drug: olmesartan; Other: placebo to LCZ696; Other: placebo to olmesartan
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified June 2013 - Condition: Osteoarthritis, Hip
Intervention: Drug: Ropivacaine
Sponsors: Golden Jubilee National Hospital; Golden Jubilee National Hospital; B. Braun Medical Inc.; University of Strathclyde
Completed - verified June 2013 - Condition: Constipation
Interventions: Other: High quantity probiotic; Other: Low quantity probiotic; Other: placebo
Sponsors: Nestlé; Nestlé
Not yet recruiting - verified June 2013 - Condition: Parkinson's Disease
Interventions: Other: Neurofeedback and Physical Exercise; Other: Physical Exercise
Sponsors: Cardiff University; Cardiff University
Recruiting - verified May 2013 - Conditions: Cognitive Ability, General; High Blood Pressure
Intervention:
Sponsors: Imperial College London; Imperial College London
Not yet recruiting - verified May 2013 - Condition: Disordered Eating
Intervention: Other: Disordered eating screening questionnaire
Sponsors: Great Ormond Street Hospital for Children NHS Foundation Trust; Great Ormond Street Hospital for Children NHS Foundation Trust
Not yet recruiting - verified June 2013 - Conditions: Paroxysmal Atrial Fibrillation; Stroke
Interventions: Device: Automated Cardiac Event Recorder; Device: Personal Heart Rhythm Monitor
Sponsors: University of Surrey; University of Surrey; Royal Surrey County Hospital NHS Foundation Trust
Recruiting - verified May 2013 - Conditions: Esophageal Neoplasm; Gastric Neoplasm
Intervention: Drug: Omegaven
Sponsors: University Hospitals, Leicester; University Hospitals, Leicester
Recruiting - verified June 2013 - Condition: Esophageal Neoplasms
Intervention: Dietary Supplement: Home jejunostomy feeding
Sponsors: University Hospitals, Leicester; University Hospitals, Leicester; University of Leicester; University of Sheffield; University of Warwick
Recruiting - verified June 2013 - Conditions: Squamous Cell Carcinoma; Breast Cancer; Skin Tumours
Interventions: Drug: Amphinex; Drug: Bleomycin; Device: Laser
Sponsors: PCI Biotech AS; PCI Biotech AS
Recruiting - verified June 2013 - Conditions: Opsoclonus Myoclonus Syndrome; Neuroblastoma
Interventions: Drug: Dexamethasone acetate; Drug: dexamethasone and cyclophosphamide; Drug: dexamethasone and rituximab
Sponsors: Institut Curie; Institut Curie
Recruiting - verified May 2013 - Condition: Muscular Dystrophy, Duchenne
Interventions: Drug: Tadalafil; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Not yet recruiting - verified June 2013 - Condition: Meibomian Gland Dysfunction
Interventions: Device: EyeBag; Other: Placebo
Sponsors: Aston University; Aston University
Recruiting - verified June 2013 - Condition: Ovarian Cancer
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified June 2013 - Condition: Influenza, Human
Intervention: Biological: Trivalent Influenza Vaccine
Sponsors: bioCSL PTY LTD; bioCSL PTY LTD
Active, not recruiting - verified June 2013 - Conditions: Chronic Stable Angina; Unstable Angina; Coronary Heart Disease Not Otherwise Specified; Acute Myocardial Infarction; Heart Failure; Ventricular Arrhythmias; Cardiac Arrest; Abdominal Aortic Aneurysm; Peripheral Arterial Disease; Ischaemic Stroke; Subarachnoid Haemorrhagic Stroke; Intracerebral Haemorrhagic Stroke; Stroke Not Otherwise Specified; Sudden Cardiac Death; Unheralded Coronary Death; Mortality; Coronary Heart Disease (CHD); Cardiovascular Disease (CVD); Fatal Cardiovascular Disease (Fatal CVD); ST Elevation Myocardial Infarction (STEMI); Non-ST Elevation Myocardial Infarction (nSTEMI); Myocardial Infarction Not Otherwise Specified (MI NOS)
Intervention:
Sponsors: University College, London; University College, London
Active, not recruiting - verified May 2013 - Conditions: Interstitial Lung Disease; Scleroderma; Idiopathic Inflammatory Myositis; Mixed Connective Tissue Disease
Interventions: Drug: Rituximab; Drug: Cyclophosphamide
Sponsors: Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; University of East Anglia; University College London Hospitals
Not yet recruiting - verified May 2013 - Condition: Healthy Male Volunteers
Interventions: Drug: ITF2984 (500, 1000, 2000 mcg bid for 7 days); Drug: octreotide 50 mcg tid; Drug: Placebo
Sponsors: Italfarmaco; Italfarmaco
Completed - verified June 2013 - Conditions: Erosive Esophagitis(EE); Gastroesophageal Reflux Disease (GERD)
Intervention: Drug: TAK-438
Sponsors: Trio Medicines Ltd.; Trio Medicines Ltd.; Takeda Global Research & Development Centre (Europe) Ltd.
Completed - verified May 2013 - Condition: Peripheral Artery Disease
Intervention: Device: Lutonix Drug Coated Balloon
Sponsors: Lutonix, Inc.; Lutonix, Inc.; Bard Ltd
Recruiting - verified May 2013 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified June 2013 - Condition: Rheumatoid Arthritis
Intervention: Biological: Certolizumab Pegol
Sponsors: University of Erlangen-Nürnberg Medical School; University of Erlangen-Nürnberg Medical School
Not yet recruiting - verified May 2013 - Condition: Deferred Umbilical Cord Clamping
Intervention:
Sponsors: University of Nottingham; University of Nottingham
Recruiting - verified June 2013 - Conditions: Bowel Cancer Screening; Analgesia; Entonox; Colonoscopy
Intervention: Drug: Entonox
Sponsors: Sheffield Teaching Hospitals NHS Foundation Trust; Sheffield Teaching Hospitals NHS Foundation Trust
Recruiting - verified May 2013 - Conditions: Patients With Coeliac Disease and Chronic Diarrhoea (>3 Loose/ Liquid Motions a Day for More Than 4 Weeks); Patients With Pancreatic Exocrine Insufficiency
Interventions: Drug: Creon; Other: Placebo
Sponsors: Sheffield Teaching Hospitals NHS Foundation Trust; Sheffield Teaching Hospitals NHS Foundation Trust; Abbott
Recruiting - verified May 2013 - Condition: Lower Respiratory Tract Infections
Intervention:
Sponsors: Royal Liverpool and Broadgreen University Hospitals NHS Trust; Royal Liverpool and Broadgreen University Hospitals NHS Trust
Recruiting - verified May 2013 - Condition: Healthy Subjects
Intervention: Device: JetTouch Needle-free injection system
Sponsors: American Medical Systems; American Medical Systems; Quintiles
Not yet recruiting - verified June 2013 - Condition: Metabolic Acidosis
Intervention:
Sponsors: Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust
Recruiting - verified May 2013 - Condition: Multiple Sclerosis (MS)
Interventions: Drug: Interferon beta 1a; Drug: (IM) AVONEX®
Sponsors: Trio Medicines Ltd.; Trio Medicines Ltd.; Biogen Idec
Completed - verified May 2013 - Conditions: Acquired Brain Injury; Emotional Distress
Intervention: Other: Psychotherapy
Sponsors: NHS Greater Glasgow and Clyde; NHS Greater Glasgow and Clyde; University of Glasgow
Not yet recruiting - verified June 2013
 |
Paid Research Studies in the United Kingdom |
Clinical Trial Locations 